Literature DB >> 10835334

HO-1 expression in type II pneumocytes after transpulmonary gene delivery.

Y H Weng1, A Tatarov, B P Bartos, C H Contag, P A Dennery.   

Abstract

Somatic cell gene transfer is a potentially useful strategy to alter lung function. However, achieving efficient transfer to the alveolar epithelium, especially in smaller animals, has not been demonstrated. In this study, the rat heme oxygenase-1 (HO-1) gene was delivered to the lungs of neonatal mice via transpulmonary injection. A bidirectional promoter construct coexpressing both HO-1 and a luciferase reporter gene was used so that in vivo gene expression patterns could be monitored in real time. HO-1 expression levels were also modulated with doxycycline and assessed in vivo with bioluminescent light transmitted through the tissues from the coregulated luciferase reporter. As a model of oxidative stress and HO-1-mediated protection, groups of animals were exposed to hyperoxia. After gene transfer, elevated levels of HO-1 were detected predominantly in alveolar type II cells by immunocytochemistry. With overexpression of HO-1, increased oxidative injury was observed. Furthermore, this model demonstrated a cell-specific effect of lung HO-1 overexpression in oxidative stress. Specific control of expression for therapeutic genes is possible in vivo. The transpulmonary approach may prove useful in targeting gene expression to cells of the alveolar epithelium or to circumscribed areas of the lung.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835334     DOI: 10.1152/ajplung.2000.278.6.L1273

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  8 in total

1.  Silencing hyperoxia-induced C/EBPα in neonatal mice improves lung architecture via enhanced proliferation of alveolar epithelial cells.

Authors:  Guang Yang; Maurice D Hinson; Jessica E Bordner; Qing S Lin; Amal P Fernando; Ping La; Clyde J Wright; Phyllis A Dennery
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

Review 2.  The role of heme oxygenase-1 in pulmonary disease.

Authors:  Laura E Fredenburgh; Mark A Perrella; S Alex Mitsialis
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-15       Impact factor: 6.914

3.  Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression.

Authors:  W Zhang; J Q Feng; S E Harris; P R Contag; D K Stevenson; C H Contag
Journal:  Transgenic Res       Date:  2001-10       Impact factor: 2.788

4.  Disrupted postnatal lung development in heme oxygenase-1 deficient mice.

Authors:  Tiangang Zhuang; Monica Zhang; Huayan Zhang; Phyllis A Dennery; Qing S Lin
Journal:  Respir Res       Date:  2010-10-10

5.  Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2,4-bisethylene glycol.

Authors:  L Atzori; F Chua; S E Dunsmore; D Willis; M Barbarisi; R J McAnulty; G J Laurent
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

6.  HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children.

Authors:  Michael Walther; Adam De Caul; Peter Aka; Madi Njie; Alfred Amambua-Ngwa; Brigitte Walther; Irene M Predazzi; Aubrey Cunnington; Susanne Deininger; Ebako N Takem; Augustine Ebonyi; Sebastian Weis; Robert Walton; Sarah Rowland-Jones; Giorgio Sirugo; Scott M Williams; David J Conway
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

7.  Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan.

Authors:  Yi-Hao Weng; Ya-Wen Chiu; Shao-Wen Cheng; Chun-Yuh Yang
Journal:  BMC Pediatr       Date:  2016-08-24       Impact factor: 2.125

8.  Prognostic value of carboxyhemoglobin in pediatric intensive care unit.

Authors:  Mehmet Alakaya; Ali Ertug Arslankoylu
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.